Based on Serum Creatinine Levels in Hypertensive Patients

Size: px
Start display at page:

Download "Based on Serum Creatinine Levels in Hypertensive Patients"

Transcription

1 Tohoku J. Exp. Med., 2011, 224, Seasonal Variation in Estimated Glomerular Filtration Rate 137 Seasonal Variation in Estimated Glomerular Filtration Rate Based on Serum Creatinine Levels in Hypertensive Patients Hisashi Masugata, 1 Shoichi Senda, 1 Michio Inukai, 1 Takashi Himoto, 1 Koji Murao, 2 Naohisa Hosomi, 3 Yasuyoshi Iwado, 4 Takahisa Noma, 4 Masakazu Kohno 4 and Fuminori Goda 1 1 Department of Integrated Medicine, Kagawa University, Kagawa, Japan 2 Department of Advanced Medicine and Laboratory Medicine, Kagawa University, Kagawa, Japan 3 Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan 4 Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Kagawa, Japan Seasonal variations in blood pressures should be kept in mind when controlling blood pressure in hypertensive patients. Seasonal variations in glomerular filtration rate (GFR) also may have a clinical significance. However, it is time-consuming to measure GFR directly. We therefore examined the seasonal variation in estimated glomerular filtration rate (egfr) based on serum creatinine levels in hypertensive patients without CKD (egfr 60 ml/min/1.73 m 2 ) and those with chronic kidney disease (CKD) (egfr < 60 ml/min/1.73 m 2 ). This study included 47 hypertensive patients without CKD (69 ± 11 yrs) and 55 hypertensive patients with CKD (76 ± 8 yrs). The egfr was determined from the equation: egfr = 194 age (serum creatinine) ( if female). Overall, both groups of hypertensive patients demonstrated similar seasonal variations in egfr. Importantly, hypertensive patients without CKD and those with CKD showed the lower egfr in summer (June-August) (71.8 ± 13.2 and 37.2 ± 13.0 ml/min/1.73 m 2, respectively) compared with the egfr in spring (March-May) (77.9 ± 13.0 and 43.0 ± 14.0 ml/min/1.73 m 2, respectively) (p < 0.05). The decrease in egfr from spring to summer was similar for both types of hypertensive patients (without CKD, 6.1 ± 7.0; with CKD, 5.8 ± 5.2 ml/min/1.73 m 2 ). However, the percent change in egfr from spring to summer was greater in hypertensive patients with CKD ( 13.8 ± 9.4 %) than in those without CKD ( 7.7 ± 8.3 %) ( p = 0.001). In conclusion, careful observation regarding renal function is needed for hypertensive patients with CKD during summer. Keywords: chronic kidney disease; creatinine; estimated glomerular filtration rate; hypertension; seasonal variation Tohoku J. Exp. Med., 2011, 224 (2), Tohoku University Medical Press Seasonal variation in arterial blood pressures has been demonstrated (Hata et al. 1982; Woodhouse et al. 1993; Imai et al. 1996; Kristal-Boneh et al. 1997), with blood pressures being higher during the winter than in the summer. From previous studies in older adults (Khaw et al. 1984; Barrett-Connor et al. 1984), a 10-mmHg rise in systolic blood pressure is associated with an approximately 10% increase in the risk of death from stroke and ischemic heart disease. Therefore, seasonal variations in blood pressures should be kept in mind when controlling blood pressure in hypertensive patients. Seasonal variations in glomerular filtration rate also may have a clinical significance. However, there are no data regarding seasonal variations in glomerular filtration rate in hypertensive patients. Renal dysfunction in patients with chronic kidney disease (CKD) has also been established as a risk of cardiovascular events, independent of conventional cardiovascular risk factors, including blood pressure (Go et al. 2004; Ninomiya et al. 2005; Irie et al. 2006; Imai et al. 2008). Therefore, in hypertensive patients, anti-hypertensive drugs (Whitworth et al. 1992; Osawa et al. 2006) and improvement of lifestyle (Orth et al. 2001) are recommended to prevent the onset or progression of CKD. The National Kidney Foundation formed a task force to heighten awareness of cardiovascular disease in CKD, and defined CKD using parameters such as a decrease in glomerular filtration rate < 60 ml/min/1.73 m 2. However, it is time-consuming to measure glomerular filtration rate directly. In Japan, an estimated glomerular filtration rate (egfr) for Japanese patients was proposed by the Japanese Society of Nephrology (Imai et al. 2007) in order to detect the early stages of CKD; however, its clinical usefulness has not Received April 18, 2011; revision accepted for publication May 18, doi: /tjem Correspondence: Hisashi Masugata, M.D., Ph.D., Department of Integrated Medicine, Kagawa University, , Miki-cho, Kita-gun, Kagawa , Japan. masugata@med.kagawa-u.ac.jp 137

2 138 H. Masugata et al. been fully established. Moreover, there are no data regarding seasonal variations of egfr in hypertensive patients, who frequently suffer from CKD. In this study, we investigated and compared the seasonal variations in egfr in hypertensive patients with and without CKD. Methods Subjects and Protocol The study subjects were 102 patients (65 male, 37 female; mean age 73 ± 10 years, range years) who had been diagnosed with hypertension at Kagawa University Hospital and who had regularly visited the outpatient clinic from spring (March, 2010-May, 2010), through winter (December, 2010-February, 2011) during one year. Hypertension was defined as systolic blood pressure 140 mmhg and/or diastolic blood pressure 90 mmhg. Blood pressure was determined using the conventional cuff method. All patients were treated with at least one antihypertensive drug. For at least one year prior to their enrollment in this study, the antihypertensive drugs did not change for any patients. In addition, the antihypertensive drugs did not change for any patients during the one-year observation period for obtaining the blood examination data. Patients with a history of heart failure or obvious heart disease were excluded. None of the patients had a history of atherosclerotic cardiovascular disease or stroke. Blood pressure was measured at an outpatient clinic every one or two months during the one-year observation period for each patient. During this period, a blood examination was performed at each season: namely, spring (March, 2010-May, 2010), summer (June, 2010-August, 2010), autumn (September, 2010-November, 2010), and winter (December, 2010-February, 2011). Blood samples were taken in the morning after an 8-hour overnight fast. Plasma total cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), serum albumin, blood urea nitrogen (BUN), serum creatinine, uric acid, hemoglobin, and hematocrit were measured by standard laboratory techniques. Serum creatinine levels were measured by using enzymatic creatinine assays. This protocol was approved by the Ethics Committee of Kagawa University. Informed consent was obtained from all participants. Estimation of Glomerular Filtration Rate (egfr) The glomerular filtration rate was estimated from the equation for Japanese patients, proposed by a working group of the Japanese Chronic Kidney Disease Initiative (Imai et al. 2007) as follows: egfr = 194 age (serum creatinine) ( if female). The average values of egfr of 4 seasons (spring, summer, autumn, and winter) were used to determine whether the participants had CKD or not. Participants with average values of egfr 60 ml/min/1.73 m 2 were included in the group of hypertensive patients without CKD, and those with average values of egfr < 60 ml/min/1.73 m 2 were included in the group of hypertensive patients with CKD. We evaluated the decrease in egfr from spring to summer by calculating the difference between the egfr values in the summer and spring. Moreover, we assessed the percent change in egfr from spring to summer as follows: Percent changes in egfr from spring to summer = (egfr summer egfr spring )/egfr spring. Statistical Analysis Data are expressed as means ± s.d.. Statistical analysis was performed using the SPSS software package (SPSS, Chicago, IL, USA). Differences between the two groups were checked by the χ 2 test for categorical variables or by the independent t-test for continuous variables. For comparison of mean values of egfr, BUN, creatinine, uric acid, hemoglobin, hematocrit, and blood pressure among Table 1. Clinical Characteristics of the Subjects. Without CKD (egfr 60 ml/min/1.73 m 2 ) With CKD (egfr < 60 ml/min/1.73 m 2 ) p value Number (male/female) 47 (27/20) 55 (38/17) Age (years) 69 ± ± 8 < BMI (kg/m 2 ) 24.0 ± ± 3.8 NS Diabetes (n (%)) 8 (17 %) 16 (29 %) NS Dyslipidemia (n (%)) 25 (53 %) 16 (51 %) NS Total cholesterol (mg/dl) 191 ± ± 30 NS HDL cholesterol (mg/dl) 54 ± ± Triglyceride (mg/dl) 111 ± ± 59 NS Serum albumin (g/dl) 4.3 ± ± Heart rate (beats/min) 71 ± ± 11 NS Anti-hypertensive drugs Diuretics (n (%)) 7 (15 %) 21 (38 %) ARB/ACEI (n (%)) 30 (64 %) 44 (80 %) NS CCB (n (%)) 32 (68 %) 32 (58 %) NS β-blocers (n (%)) 15 (32 %) 12 (22 %) NS α-blockers (n (%)) 4 (9 %) 5 (9 %) NS CKD, chronic kidney disease; BMI, body mass index; HDL, high-density lipoprotein; egfr, estimated glomerular filtration rate; ARB, angiotensin II receptor blockers; ACEI, angiotensin converting enzyme inhibitors; CCB, calcium channel blockers.

3 Seasonal Variation in Estimated Glomerular Filtration Rate 139 the 4 seasons, the one-way analysis of variance (ANOVA) test was used, and post hoc comparisons were made using least square differences test. Values of p < 0.05 were considered to indicate statistical significance. Results Clinical Characteristics of Subjects The clinical and egfr parameters of the subjects are summarized in Table 1. The mean age and serum uric acid level were significantly higher in patients with CKD than in those without CKD. The diastolic blood pressure, HDLcholesterol, serum albumin, and hemoglobin were significantly lower in patients with CKD than in those without CKD. The prevalence of diuretics used as anti-hypertensive drugs was significantly higher in patients with CKD than in those without CKD. Seasonal Variations in BUN, Creatinine, Uric Acid, Hemoglobin, Hematocrit, and Blood Pressure Although the values of BUN, creatinine, hemoglobin, Table 2. Comparison of Seasonal Variations of BUN, Creatinine, Uric Acid, Hemoglobin, Hematocrit, and Blood Pressure between the Two Groups. Without CKD (egfr 60 ml/min/1.73 m 2 ) With CKD (egfr < 60 ml/min/1.73 m 2 ) BUN BUN spring (mg/dl) 19.8 ± ± 10.3 BUN summer (mg/dl) 22.0 ± ± 14.6 BUN autumn (mg/dl) 20.6 ± ± 12.0 BUN winter (mg/dl) 20.9 ± ± 11.7 Creatinine Creatinine spring (mg/dl) 0.93 ± ± 0.62 Creatinine summer (mg/dl) 1.04 ± ± 0.81 Creatinine autumn (mg/dl) 0.95 ± ± 0.67 Creatinine winter (mg/dl) 0.94 ± ± 0.66 Uric acid Uric acid spring (mg/dl) 6.0 ± ± 1.3 Uric acid summer (mg/dl) 6.5 ± ± 1.7* # Uric acid autumn (mg/dl) 6.1 ± ± 1.6 Uric acid winter (mg/dl) 6.0 ± ± 1.3 Hemoglobin Hemoglobin spring (g/dl) 13.4 ± ± 1.7 Hemoglobin summer (g/dl) 13.0 ± ± 1.7 Hemoglobin autumn (g/dl) 13.4 ± ± 1.7 Hemoglobin winter (g/dl) 13.4 ± ± 1.7 Hematocrit Hematocrit spring (%) 40.5 ± ± 4.5 Hematocrit summer (%) 39.0 ± ± 4.8 Hematocrit autumn (%) 40.0 ± ± 5.1 Hematocrit winter (%) 40.9 ± ± 4.8 SBP SBP spring (mmhg) 137 ± ± 20 SBP summer (mmhg) 132 ± ± 18 SBP autumn (mmhg) 138 ± ± 20 SBP winter (mmhg) 136 ± ± 19 DBP DBP spring (mmhg) 75 ± ± 12 DBP summer (mmhg) 72 ± ± 12 DBP autumn (mmhg) 74 ± ± 12 DBP winter (mmhg) 72 ± ± 12 BUN, blood urea nitrogen; SBP, systolic blood pressure; DBP, diastolic blood pressure. *p<0.05 vs Uric acid spring ; # p<0.05 vs Uric acid winter ; p<0.05 vs SBP spring, SBP autumn, and SBP winter.

4 140 H. Masugata et al. Table 3. Comparison of Seasonal Variation of egfr between the Two Groups. Without CKD (egfr 60 ml/min/1.73 m 2 ) With CKD (egfr < 60 ml/min/1.73 m 2 ) egfr spring (ml/min/1.73 m 2 ) 77.9 ± ± 14.0 egfr summer (ml/min/1.73 m 2 ) 71.8 ± 13.2* 37.2 ± 13.0* # egfr autumn (ml/min/1.73 m 2 ) 76.2 ± ± 13.9 egfr winter (ml/min/1.73 m 2 ) 76.4 ± ± 14.2 egfr summer egfr spring (ml/min/1.73 m 2 ) 6.1 ± ± 5.2 % chage in egfr from spring to summer (%) 7.7 ± ± 9.4 egfr, estimated glomerular filtration rate; CKD, chronic kidney disease. *p < 0.05 vs egfr spring ; # p < 0.05 vs egfr winter. Fig. 1. Comparison of seasonal egfr variations in hypertensive patients with and without CKD. The two groups demonstrated similar seasonal variations in egfr. The egfr was the lowest in the summer (June-August) for both groups. The egfr in the summer (June-August) was statistically lower than that in spring (March-May) for both groups (p < 0.05). egfr, estimated glomerular filtration rate. and hematocrit did not show statistically significant differences among the 4 seasons, the value of uric acid increased in summer in patients with CKD ( p = 0.027) (Table 2). Diastolic blood pressure did not differ among the 4 seasons. However, systolic blood pressure decreased in summer in patients with CKD ( p = 0.034). Seasonal Variations in egfr The comparisons of seasonal variations in egfr between hypertensive patients with and without CKD are summarized in Table 3. Because we divided the participants into two groups based on egfr, the mean values of egfr were significantly lower in patients with CKD than in those without CKD during each season ( p < 0.001). Both groups demonstrated similar seasonal variations in egfr (Fig. 1). The egfr was the lowest in the summer (June August) for both groups. The egfr in the summer (June-August) was significantly lower than that in spring (March-May) for both patients without CKD ( p = 0.024) and those with CKD (p = 0.028). The decrease in egfr from spring to summer was similar for both groups (without CKD, 6.1 ± 7.0; with CKD, 5.8 ± 5.2 ml/min/1.73 m 2 ). However, the percent change in egfr from spring to summer was significantly greater in patients with CKD ( 13.8 ± 9.4 %) than the percent change in egfr in those without CKD ( 7.7 ± 8.3 %) (p = 0.001). Thus, the degree of the decrease in egfr was greater in patients with CKD. Influences of Prescribed Antihypertensives and Age on Seasonal Variations in egfr We compared the seasonal variation of egfr between patients with and without the combination of renin-angiotensin system (RAS) inhibitors and diuretics. We found that the seasonal variation of egfr was greater in 25 patients ( 14.0 ± 11.0 %) with the combination of RAS inhibitors and diuretics than in 77 patients ( 8.4 ± 7.1 %) without the combination of RAS inhibitors and diuretics ( p = 0.004). In addition, we compared the seasonal variation of egfr between 53 elderly (age 73 yrs) and 49 young (age < 73 yrs) patients. We found that the seasonal variation of egfr was greater in elderly patients ( 12.2 ± 9.8 %) than in young patients ( 7.2 ± 6.0 %) (p = 0.002).

5 Seasonal Variation in Estimated Glomerular Filtration Rate 141 Discussion The present study has revealed the seasonal variations in egfr in hypertensive patients with and without CKD. The data led us to the following conclusions: (1) egfr is the lowest in the summer for hypertensive patients with and without CKD; (2) although the reduction in egfr from spring to summer is similar for hypertensive patients with and without CKD, the percent change in egfr from spring to summer is greater in hypertensive patients with CKD than in those without CKD. The most striking result in our analysis was that human egfr values appear to decrease in the summer. Although some previous animal studies have demonstrated seasonal variation in the glomerular filtration rate, consensus is still lacking. Nawaz and Shah (1984) reported that the plasma concentrations of endogenous creatinine and urea in sheep were significantly higher because of haemoconcentration during summer, resulting in a lower glomerular filtration rate than in the winter. By contrast, Tsuda et al. (1995) reported that the glomerular filtration rate of sheep was significantly higher in the summer than in the winter. These controversial results may be attributed to the differences in the methodology for assessing glomerular filtration rates. As our human study estimated glomerular filtration rate using the equation proposed by the working group of the Japanese Chronic Kidney Disease Initiative, the seasonal variation in egfr may have mainly reflected the seasonal changes in serum creatinine levels. In this observational study, patients serum creatinine levels may have increased because of dehydration during summer. However, the seasonal changes in serum creatinine levels were not statistically significant (Table 2). In contrast, the systolic blood pressure and uric acid levels were decreased in summer in patients with CKD. Therefore, the seasonal variation in egfr in the present study may be produced in part by dehydration during summer. Moreover, prescribed antihypertensives and age may influence the seasonal variation of egfr. The seasonal variation in egfr demonstrated in the present study suggests that careful observation for dehydration may be needed to prevent a decrease in egfr in hypertensive patients with CKD. Hydration could be a treatment to prevent decrease in egfr in summer. The decrease in egfr in the summer was not enormous, either for hypertensive patients without CKD ( 6.1 ± 7.0 ml/min/1.73 m 2 ) or those with CKD ( 5.8 ± 5.2 ml/min/1.73 m 2 ). However, the baseline egfr in spring was lower in patients with CKD (43.0 ± 14.0 ml/min/1.73 m 2 ) than in those without CKD (77.9 ± 13.0 ml/min/1.73 m 2 ). Therefore, the percent reduction was greater in patients with CKD ( 13.8 ± 9.4 %) than in those without CKD ( 7.7 ± 8.3 %). Patients with CKD showed improvement of egfr in the autumn and winter, and did not show significant deterioration of renal function during the one-year observation. However, a previous study (Sasaki et al. 1975) demonstrated that patients with chronic glomerular nephritis submitted to repeated upright posture exhibited a decrease in the glomerular filtration rate with decreased circulating plasma volume. Therefore, further studies for a longer duration of observation may be needed to determine the effects of decreased egfr in the summer, possibly resulting from haemoconcentration or dehydration, on the prognosis of renal function in hypertensive patients. The limitation of the present study was that we did not assess renal function by 24-hour urine collection. We did not perform direct measurement of GFR by using the clearance of exogenous markers. Therefore, egfr based on serum creatinine levels in the present study may be different from the true seasonal variations in glomerular filtration rate to some degree. In conclusion, egfr is the lowest in the summer for hypertensive patients with CKD and those without CKD. Because the degree of the seasonal variations in egfr is greater in patients with CKD, careful observation regarding renal function is needed for hypertensive patients with CKD during summer. Conflict of Interest The authors declare no conflict of interest. References Barrett-Connor, E., Suarez, L., Khaw, K., Criqui, M.H. & Wingard, D.L. (1984) Ischemic heart disease risk factors after age 50. J. Chronic. Dis., 37, Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E. & Hsu, C.Y. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med., 351, Hata, T., Ogihara, T., Maruyama, A., Mikami, H., Nakamaru, M., Naka, T., Kumahara, Y. & Nugent, C.A. (1982) The seasonal variation of blood pressure in patients with essential hypertension. Clin. Exp. Hypertens., 4, Imai, E., Horio, M., Nitta, K., Yamagata, K., Iseki, K., Hara, S., Ura, N., Kiyohara, Y., Hirakata, H., Watanabe, T., Moriyama, T., Ando, Y., Inaguma, D., Narita, I., Iso, H., Wakai, K., Yasuda, Y., Tsukamoto, Y., Ito, S., Makino, H., Hishida, A. & Matsuo, S. (2007) Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin. Exp. Nephrol., 11, Imai, E., Matsuo, S., Makino, H., Watanabe, T., Akizawa, T., Nitta, K., Iimuro, S., Ohashi, Y. & Hishida, A.; CKD-JAC Study Group. (2008) Chronic Kidney Disease Japan Cohort (CKD- JAC) study: design and methods. Hypertens. Res., 31, Imai, Y., Munakata, M., Tsuji, I., Ohkubo, T., Satoh, H., Yoshino, H., Watanabe, N., Nishiyama, A., Onodera, N., Kato, J., Sekino, M., Aihara, A., Kasai, Y. & Abe, K. (1996) Seasonal variation in blood pressure in normotensive women studied by home measurements. Clin. Sci., (Lond) 90, Irie, F., Iso, H., Sairenchi, T., Fukasawa, N., Yamagishi, K., Ikehara, S., Kanashiki, M., Saito, Y., Ota, H. & Nose, T. (2006) The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int., 69, Khaw, K.T., Barrett-Connor, E., Suarez, L. & Criqui, M.H. (1984) Predictors of stroke-associated mortality in the elderly. Stroke, 15, Kristal-Boneh, E., Harari, G. & Green, M.S. (1997) Seasonal change in 24-hour blood pressure and heart rate is greater

6 142 H. Masugata et al. among smokers than nonsmokers. Hypertension, 30(3 Pt 1), Nawaz, M. & Shah, B.H. (1984) Renal clearance of endogenous creatinine and urea in sheep during summer and winter. Res. Vet. Sci., 36, Ninomiya, T., Kiyohara, Y., Kubo, M., Tanizaki, Y., Doi, Y., Okubo, K., Wakugawa, Y., Hata, J., Oishi, Y., Shikata, K., Yonemoto, K., Hirakata, H. & Iida, M. (2005) Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int., 68, Orth, S.R., Viedt, C. & Ritz, E. (2001) Adverse effects of smoking in the renal patient. Tohoku J. Exp. Med., 194, Osawa, H., Nakamura, N., Shirato, K., Nakamura, M., Shimada, M., Kumasaka, R., Murakami, R., Fujita, T., Yamabe, H. & Okumura, K. (2006) Losartan, an angiotensin-ii receptor antagonist, retards the progression of advanced renal insufficiency. Tohoku J. Exp. Med., 209, Sasaki, Y., Furuyama, T., Shioji, R. & Ueda, H. (1975) Circulating plasma volume and renal function. Tohoku J. Exp. Med., 116, Tsuda, T., Ide, M. & Iigo, M. (1995) Influences of season and of temperature, photoperiod, and subcutaneous melatonin infusion on the glomerular filtration rate of ewes. J. Pineal Res., 19, Whitworth, J.A., Ihle, B.U., Becker, G.J. & Kincaid-Smith, P.S. (1992) Preservation of renal function in chronic renal failure. Tohoku J. Exp. Med., 166, Woodhouse, P.R., Khaw, K.T. & Plummer, M. (1993) Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J. Hypertens., 11,

Differences in the Local and National Prevalences of CKD Based on Annual Health Check Program Data

Differences in the Local and National Prevalences of CKD Based on Annual Health Check Program Data Original article Differences in the Local and National Prevalences of CKD Based on Annual Health Check Program Data Minako Wakasugi *, Junichiro James Kazama, and Ichiei Narita * Center for Inter-organ

More information

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Environ Health Prev Med (2011) 16:191 195 DOI 10.1007/s12199-010-0183-9 SHORT COMMUNICATION The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan Nobuyuki

More information

Increased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects

Increased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects ORIGINAL ARTICLE Increased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects Shu Meguro, Toshikatsu Shigihara, Yusuke Kabeya, Masuomi Tomita

More information

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage

More information

Masatoshi Kawashima 1, Koji Wada 2, Hiroshi Ohta 2, Rika Moriya 3 and Yoshiharu Aizawa 1. Journal of Occupational Health

Masatoshi Kawashima 1, Koji Wada 2, Hiroshi Ohta 2, Rika Moriya 3 and Yoshiharu Aizawa 1. Journal of Occupational Health 176 J Occup Health, Vol. 54, 2012 J Occup Health 2012; 54: 176 180 Journal of Occupational Health Evaluation of Validity of the Urine Dipstick Test for Identification of Reduced Glomerular Filtration Rate

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA

More information

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose. JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

Relationship between Estimated Glomerular Filtration Rate (egfr) and Metabolic Syndrome in Japanese

Relationship between Estimated Glomerular Filtration Rate (egfr) and Metabolic Syndrome in Japanese Relationship between Estimated Glomerular Filtration Rate (egfr) and Metabolic Syndrome in Japanese a* b b c a b c ʼ Clinical profiles of subjects in the first analysis Men (n 3,674) Women (n 8,037) Mean

More information

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation

More information

Kidney Disease Screening Program in Japan: History, Outcome, and Perspectives

Kidney Disease Screening Program in Japan: History, Outcome, and Perspectives Special Feature: Screening Series Kidney Disease Screening Program in Japan: History, Outcome, and Perspectives Enyu Imai,* Kunihiro Yamagata, Kunitoshi Iseki, Hiroyasu Iso, Masaru Horio,* Hirofumi Mkino,

More information

Ezetimibe Reduces Urinary Albumin Excretion in Hypercholesterolaemic Type 2 Diabetes Patients with Microalbuminuria

Ezetimibe Reduces Urinary Albumin Excretion in Hypercholesterolaemic Type 2 Diabetes Patients with Microalbuminuria The Journal of International Medical Research 2012; 40: 798 803 Ezetimibe Reduces Urinary Albumin Excretion in Hypercholesterolaemic Type 2 Diabetes Patients with Microalbuminuria T NAKAMURA 1, E SATO

More information

Clinical Study Factors Associated with the Decline of Kidney Function Differ among egfr Strata in Subjects with Type 2 Diabetes Mellitus

Clinical Study Factors Associated with the Decline of Kidney Function Differ among egfr Strata in Subjects with Type 2 Diabetes Mellitus International Endocrinology Volume 2012, Article ID 687867, 6 pages doi:10.1155/2012/687867 Clinical Study Factors Associated with the Decline of Kidney Function Differ among egfr Strata in Subjects with

More information

The effect of a change in ambient temperature on blood pressure in normotensives

The effect of a change in ambient temperature on blood pressure in normotensives (2001) 15, 113 117 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE The effect of a change in ambient temperature on blood pressure in normotensives

More information

Reducing proteinuria

Reducing proteinuria Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors

More information

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC

More information

Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors

Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors The Journal of International Medical Research 2011; 39: 64 70 Aortic Root Dilatation as a Marker of Subclinical Left Ventricular Diastolic Dysfunction in Patients with Cardiovascular Risk Factors H MASUGATA,

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

Association Between Residual Kidney Function and Visit-to-Visit Blood Pressure Variability in Peritoneal Dialysis Patients

Association Between Residual Kidney Function and Visit-to-Visit Blood Pressure Variability in Peritoneal Dialysis Patients Advances in Peritoneal Dialysis, Vol. 31, 2015 Kei Yokota, 1,2 Tsutomu Sakurada, 1 Kenichiro Koitabashi, 1 Yugo Shibagaki, 1 Kazuomi Kario, 2 Kenjiro Kimura 3 Association Between Residual Kidney Function

More information

Early rehospitalization after initial chronic kidney disease educational hospitalization relates with a multidisciplinary medical team

Early rehospitalization after initial chronic kidney disease educational hospitalization relates with a multidisciplinary medical team Kose et al. Journal of Pharmaceutical Health Care and Sciences (2016) 2:27 DOI 10.1186/s40780-016-0061-8 RESEARCH ARTICLE Open Access Early rehospitalization after initial chronic kidney disease educational

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel

More information

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University

More information

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2

More information

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease Clin Exp Nephrol (2013) 17:730 742 DOI 10.1007/s10157-012-0758-4 ORIGINAL ARTICLE Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease Kosaku Nitta Satoshi Iimuro

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Elevated Brachial-Ankle Pulse Wave Velocity Is Associated with Left Ventricular Hypertrophy in Hypertensive Patients after Stroke

Elevated Brachial-Ankle Pulse Wave Velocity Is Associated with Left Ventricular Hypertrophy in Hypertensive Patients after Stroke Tohoku J. Exp. Med., 2010, 220, 177-182 Pulse Wave Velocity in Stroke 177 Elevated Brachial-Ankle Pulse Wave Velocity Is Associated with Left Ventricular Hypertrophy in Hypertensive Patients after Stroke

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure

More information

Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up

Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up 1169 Original Article Hypertens Res Vol.30 (2007) No.12 p.1169-1175 Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Metabolic Syndrome and Chronic Kidney Disease

Metabolic Syndrome and Chronic Kidney Disease Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference

More information

Methods. Study design

Methods. Study design Elmer ress Original Article J Clin Med Res. 2017;9(2):98-103 Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide

More information

Blood Pressure Control in a Japanese Population With Chronic Kidney Disease: A Baseline Survey of a Nationwide Cohort

Blood Pressure Control in a Japanese Population With Chronic Kidney Disease: A Baseline Survey of a Nationwide Cohort original contributions nature publishing group Blood Pressure Control in a Japanese Population With Chronic Kidney Disease: A Baseline Survey of a Nationwide Cohort Tsuneo Konta 1, Ami Ikeda 1, Kazunobu

More information

Hiroyuki Daikuhara 1, Fumi Kikuchi 2 and Toshihiko Ishida 2. Introduction. Original Article

Hiroyuki Daikuhara 1, Fumi Kikuchi 2 and Toshihiko Ishida 2. Introduction. Original Article 447310DVR9410.1177/1479164112447310Daikuhara et al.diabetes and Vascular Disease Research 2012 Original Article The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan

More information

2 Furthermore, quantitative coronary angiography

2 Furthermore, quantitative coronary angiography ORIGINAL PAPER Estimated Glomerular Filtration Rate Reversal by Blood Pressure Lowering in Chronic Kidney Disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD Study Yoshiki Yui, MD;

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Chronic kidney disease in patients with ileal conduit urinary diversion

Chronic kidney disease in patients with ileal conduit urinary diversion 962 Chronic kidney disease in patients with ileal conduit urinary diversion TOSHIHIDE NAGANUMA 1, YOSHIAKI TAKEMOTO 1, SATOSHI MAEDA 1, TOMOAKI IWAI 1, NOBUYUKI KUWABARA 1, TETSUO SHOJI 2, MIKIO OKAMURA

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme

More information

The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population

The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population original article http://www.kidney-international.org & 2006 International Society of Nephrology The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart

More information

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

Reframe the Paradigm of Hypertension treatment Focus on Diabetes Reframe the Paradigm of Hypertension treatment Focus on Diabetes Paola Atallah, MD Lecturer of Clinical Medicine SGUMC EDL monthly meeting October 25,2016 Overview Physiopathology of hypertension Classification

More information

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure. Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test

More information

Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography

Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography Original Paper Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography Ryoko Mitsutake, MD, PhD; Shin-ichiro Miura, MD, PhD; Yuhei Shiga, MD; Yoshinari

More information

Hypertension in Geriatrics. Dr. Allen Liu Consultant Nephrologist 10 September 2016

Hypertension in Geriatrics. Dr. Allen Liu Consultant Nephrologist 10 September 2016 Hypertension in Geriatrics Dr. Allen Liu Consultant Nephrologist 10 September 2016 Annual mortality (%) Cardiovascular Mortality Rates are Higher among Dialysis Patients 100 10 1 0.1 0.01 0.001 25-34

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Janice P. Lea, MD, MSc, FASN Professor of Medicine Chief Medical Director of Emory Dialysis ASH Clinical Specialist

More information

Kidney disease is increasingly being recognized as a

Kidney disease is increasingly being recognized as a Impact of Kidney Disease and Blood Pressure on the Development of Cardiovascular Disease An Overview From the Japan Arteriosclerosis Longitudinal Study Toshiharu Ninomiya, MD, PhD; Yutaka Kiyohara, MD,

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

Hypertension is a major risk factor for stroke in developed

Hypertension is a major risk factor for stroke in developed Prediction of Stroke by Self-Measurement of Blood Pressure at Home Versus Casual Screening Blood Pressure Measurement in Relation to the Joint National Committee 7 Classification The Ohasama Study Kei

More information

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers Medical parameters Cut-off values BMI (kg/m 2 ) 25.0 Waist (cm) (Men and Women) (Men) 85, (Women) 90

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

THE IMPACT OF CCB AND RAS INHIBITOR COMBINATION THERAPY TO PREVENT CKD INCIDENCE IN HYPERTENSION AND ADVANCED ATHEROSCLEROSIS

THE IMPACT OF CCB AND RAS INHIBITOR COMBINATION THERAPY TO PREVENT CKD INCIDENCE IN HYPERTENSION AND ADVANCED ATHEROSCLEROSIS THE IMPACT OF CCB AND RAS INHIBITOR COMBINATION THERAPY TO PREVENT CKD INCIDENCE IN HYPERTENSION AND ADVANCED ATHEROSCLEROSIS Daisuke MAEBUCHI, Yasuyuki SHIRAISHI, Hiroaki TANAKA, Yumiko INUI, Makoto TAKEI,

More information

hypertension Head of prevention and control of CVD disease office Ministry of heath

hypertension Head of prevention and control of CVD disease office Ministry of heath hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension

More information

ORIGINAL ARTICLE. Keywords: albuminuria; beta2-microglobulin; salt intake

ORIGINAL ARTICLE. Keywords: albuminuria; beta2-microglobulin; salt intake (2011) 34, 831 835 & 2011 The Japanese Society of Hypertension All rights reserved 0916-9636/11 $32.00 www.nature.com/hr ORIGINAL ARTICLE Increases in urinary albumin and beta2-microglobulin are independently

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS

THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS 214 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(3):23-212 doi: 1.2478/rjdnmd-214-25 THE PROGNOSIS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND DIABETES

More information

Blood Pressure Goal in Elderly Hypertensive Patients with Diabetes Mellitus: A Subanalysis of the CASE-J Trial

Blood Pressure Goal in Elderly Hypertensive Patients with Diabetes Mellitus: A Subanalysis of the CASE-J Trial Blood Pressure Goal in Elderly Hypertensive Patients with Diabetes Mellitus: A Subanalysis of the CASE-J Trial Kenji Ueshima 1, Shinji Yasuno 1, Sachiko Tanaka 1, Akira Fujimoto 1, Toshio Ogihara 2, Takao

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure 801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Cardiovascular Diseases in CKD

Cardiovascular Diseases in CKD 1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9

More information

Update on Current Trends in Hypertension Management

Update on Current Trends in Hypertension Management Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of

More information

Figure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis).

Figure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis). Chronic Kidney Disease (CKD): The New Silent Killer Nelson Kopyt D.O. Chief of Nephrology, LVH Valley Kidney Specialists For the past several decades, the health care needs of Americans have shifted from

More information

Chronic Kidney Disease Increases Cardiovascular Mortality in 80-Year-Old Subjects in Japan

Chronic Kidney Disease Increases Cardiovascular Mortality in 80-Year-Old Subjects in Japan 2053 Original Article Hypertens Res Vol.31 (2008) No.11 p.2053-2058 Chronic Kidney Disease Increases Cardiovascular Mortality in 80-Year-Old Subjects in Japan Shuntaro KAGIYAMA 1),2), Kiyoshi MATSUMURA

More information

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing

More information

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication 41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth

More information

Guidelines for clinical evaluation of chronic kidney disease

Guidelines for clinical evaluation of chronic kidney disease https://doi.org/10.1007/s10157-018-1615-x GUIDELINE Guidelines for clinical evaluation of chronic kidney disease AMED research on regulatory science of pharmaceuticals and medical devices Eiichiro Kanda

More information

ORIGINAL ARTICLE. Abstract. Introduction. Minako Wakasugi 1, Junichiro James Kazama 2 and Ichiei Narita 2

ORIGINAL ARTICLE. Abstract. Introduction. Minako Wakasugi 1, Junichiro James Kazama 2 and Ichiei Narita 2 ORIGINAL ARTICLE Associations between the Intake of Miso Soup and Japanese Pickles and the Estimated 24-hour Urinary Sodium Excretion: A Population-based Cross-sectional Study Minako Wakasugi 1, Junichiro

More information

Hypertension and Cardiovascular Disease

Hypertension and Cardiovascular Disease Hypertension and Cardiovascular Disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,

More information

Tae Yamamoto Masaaki Nakayama Mariko Miyazaki Masato Matsushima Toshinobu Sato Yoshio Taguma Hiroshi Sato Sadayoshi Ito

Tae Yamamoto Masaaki Nakayama Mariko Miyazaki Masato Matsushima Toshinobu Sato Yoshio Taguma Hiroshi Sato Sadayoshi Ito Clin Exp Nephrol (2015) 19:878 886 DOI 10.1007/s10157-015-1084-4 ORIGINAL ARTICLE Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease

More information

Long-term study of the association of adipokines and glucose variability with diabetic complications

Long-term study of the association of adipokines and glucose variability with diabetic complications ORIGINAL ARTICLE Korean J Intern Med 2018;33:367-382 Long-term study of the association of adipokines and glucose variability with diabetic complications Jin Joo Cha, Hye Sook Min, Kitae Kim, Mi Jin Lee,

More information

Rationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source:

Rationale: Objectives: Indication: Diabetes Mellitus, Type 2 Study Investigators/Centers: 300 physicians in 292 clinics Research Methods: Data Source: GSK Medicine: N/A Study No.: 112255 Title: A Korean, multi-center, nation-wide, cross-sectional, epidemiology study to identify prevalence of diabetic nephropathy in hypertensive patients with type 2 diabetes

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information

Egyptian Hypertension Guidelines

Egyptian Hypertension Guidelines Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich

More information

A Newly Estimated Glomerular Filtration Rate Is Independently Associated with Arterial Stiffness in Japanese Patients

A Newly Estimated Glomerular Filtration Rate Is Independently Associated with Arterial Stiffness in Japanese Patients 193 Original Article Hypertens Res Vol.31 (2008) No.2 p.193-201 A Newly Estimated Glomerular Filtration Rate Is Independently Associated with Arterial Stiffness in Japanese Patients Naoki NAKAGAWA 1),2),

More information

Renal Protection Staying on Target

Renal Protection Staying on Target Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary

More information

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM Are Particular Anti-hypertensives More Effective or Harmful Than Others in Hypertension in Pregnancy? Existing data is inadequate Methyldopa and

More information

The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function

The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function doi: 10.2169/internalmedicine.0994-18 Intern Med 57: 3241-3247, 2018 http://internmed.jp ORIGINAL ARTICLE The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System

More information

Blood Pressure Monitoring in Chronic Kidney Disease

Blood Pressure Monitoring in Chronic Kidney Disease Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American

More information

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine

More information

Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese Community

Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese Community Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Renal Disease Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese

More information

Research Article The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease

Research Article The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease International Nephrology Volume 2015, Article ID 485839, 6 pages http://dx.doi.org/10.1155/2015/485839 Research Article The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic

More information

Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine

Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine 831 Original Article Hypertens Res Vol.3 (27) No.9 p.831-837 Effectiveness of Add-On Low-Dose Diuretics in Combination Therapy for Hypertension: Losartan/Hydrochlorothiazide vs. Candesartan/Amlodipine

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension (2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers

More information

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste University of Groningen Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 37 Effective Health Care Program Chronic Kidney Disease Stages 1 3: Screening, Monitoring, and Treatment Executive Summary Objectives This systematic review evaluates

More information

Evaluation of CKD-EPI and MDRD Prediction Equations for Estimation of GFR in Lean and Obese Bangladeshi Subjects

Evaluation of CKD-EPI and MDRD Prediction Equations for Estimation of GFR in Lean and Obese Bangladeshi Subjects Available Online Publications J. Sci. Res. 5 (1), 207-213 (2013) JOURNAL OF SCIENTIFIC RESEARCH www.banglajol.info/index.php/jsr Short Communication Evaluation of CKD-EPI and MDRD Prediction Equations

More information

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,

More information

The Latest Generation of Clinical

The Latest Generation of Clinical The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform

More information

Aggressive blood pressure reduction and renin angiotensin system blockade in chronic kidney disease: time for re-evaluation?

Aggressive blood pressure reduction and renin angiotensin system blockade in chronic kidney disease: time for re-evaluation? http://www.kidney-international.org & 2013 International Society of Nephrology Aggressive blood pressure reduction and renin angiotensin system blockade in chronic kidney disease: time for re-evaluation?

More information